By Editor • September 2, 2026 • 1 min read
Ultragenyx's GTX-102 for Angelman syndrome has failed a Phase 3 trial, dashing hopes for affected families and the company's profitability.
Read moreBy Editor • September 2, 2026 • 1 min read
Prime Minister Shehbaz Sharif pledges strict accountability for officials linked to the tragic Pims fire that killed 14 infants.
Read moreBy Editor • September 2, 2026 • 1 min read
A recent report reveals a surge in complaints about autism and ADHD care, highlighting the lack of treatment access following diagnoses.
Read moreBy Editor • September 2, 2026 • 1 min read
Alison Smith argues against banning nuts on flights, stating such measures do not improve compliance and can create false security for allergy sufferers.
Read moreBy Editor • September 2, 2026 • 1 min read
A new at-home urine test can accurately detect over 90% of bladder cancer cases, potentially transforming patient diagnosis and care.
Read moreBy Editor • September 2, 2026 • 1 min read
Medical organizations have released new vaccination guidelines to help combat respiratory illnesses this winter.
Read moreBy Editor • September 2, 2026 • 1 min read
ARPA-H is funding biotechs developing personalized RNA therapies, while UniQure seeks approval for its Huntington's disease treatment.
Read moreBy Editor • September 2, 2026 • 2 min read
HHS promotes its new children's book 'The Magic Tablet' at an event encouraging real-life experiences over screen time.
Read moreBy Editor • September 2, 2026 • 1 min read
Planning is key for cancer patients wanting to travel, with insurance and medication management being top priorities.
Read moreBy Editor • September 2, 2026 • 1 min read
New lightweight sunscreens challenge the stereotype of greasiness, urging UK adults to reconsider their daily SPF habits.
Read more
